No Data
Morgan Stanley raised the Target Price for Oracle (ORCL.US) to $175, maintaining a "Market Perform" rating.
Morgan Stanley published a Research Report indicating that Oracle (ORCL.US) saw its remaining performance obligations (RPO) decrease from 99 billion USD to 97 billion USD in the second fiscal quarter, reflecting a year-on-year decline of about 11% in order volume during the period. The proportion of order volume based on current remaining performance obligations (cRPO) also dropped from 16% to 13%. Due to the shift from an increase to a decrease in order volume, and the performance in the second fiscal quarter as well as the guidance for the third fiscal quarter both falling short of market expectations, Morgan Stanley anticipates that investors' focus will shift back to revenue performance, with potential currency risk increasing, believing it will be a challenge for management to achieve double-digit growth goals. At the same time, due to capital expenditure.
Global governments and technology giants are accelerating their plans, with Uranium mining and nuclear energy gaining momentum.
With the accelerated planning of Global Technology giants and governments, the long-term prospects of the nuclear energy Industry remain optimistic.
Argus Research Maintains Oracle(ORCL.US) With Buy Rating, Raises Target Price to $200
Data Integration Solution From Precisely Now Available on Google Cloud Marketplace
Big Stock Stories on Alphabet, Oracle, and T-Mobile
Microsoft, Amazon, Big Tech Set to 'Accelerate' Deals With Khan Departure: Wedbush